Compare Stocks → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:AMTOTCMKTS:EMED Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMTAmerican Tower$184.16-1.2%$188.37$154.58▼$219.10$85.88B0.712.45 million shs890,123 shsEMEDElectromedical Technologies$0.00-15.4%$0.00$0.00▼$0.00N/AN/A2.33 million shs1.60 million shs7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMTAmerican Tower+2.80%+3.76%-3.37%-4.11%-5.06%EMEDElectromedical Technologies-14.29%+20.00%-14.29%-14.29%-76.00%Elon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMTAmerican Tower4.8172 of 5 stars3.53.02.53.13.22.51.9EMEDElectromedical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMTAmerican Tower2.91Moderate Buy$221.9120.50% UpsideEMEDElectromedical TechnologiesN/AN/AN/AN/ACurrent Analyst RatingsLatest EMED, 4DX, ADR, and AMT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/1/2024AMTAmerican TowerScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Outperform ➝ Sector Outperform$243.00 ➝ $223.005/1/2024AMTAmerican TowerBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$228.00 ➝ $220.005/1/2024AMTAmerican TowerRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeOutperform ➝ Strong-Buy$226.00 ➝ $248.004/15/2024AMTAmerican TowerMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$183.00 ➝ $196.004/8/2024AMTAmerican TowerMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$205.003/5/2024AMTAmerican TowerBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$224.00 ➝ $234.002/28/2024AMTAmerican TowerBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$235.00 ➝ $228.002/28/2024AMTAmerican TowerJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$236.00 ➝ $230.00(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMTAmerican Tower$11.14B7.71$10.04 per share18.34$23.30 per share7.90EMEDElectromedical TechnologiesN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMTAmerican Tower$1.48B$4.4241.6717.841.4318.42%18.45%3.11%7/25/2024 (Estimated)EMEDElectromedical TechnologiesN/AN/A0.00∞N/AN/AN/AN/AN/ALatest EMED, 4DX, ADR, and AMT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2024Q1 2024AMTAmerican Tower$2.43$1.96-$0.47$1.96$2.79 billion$2.83 billion 2/27/202412/31/2023AMTAmerican Tower$2.10$0.94-$1.16$0.18$2.74 billion$2.79 billion DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMTAmerican Tower$6.483.52%+12.50%146.61%N/AEMEDElectromedical TechnologiesN/AN/AN/AN/AN/ALatest EMED, 4DX, ADR, and AMT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/14/2024AMTAmerican Towerquarterly$1.623.3%4/11/20244/12/20244/26/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMTAmerican Tower3.390.850.85EMEDElectromedical TechnologiesN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMTAmerican Tower92.69%EMEDElectromedical Technologies0.01%Insider OwnershipCompanyInsider OwnershipAMTAmerican Tower0.18%EMEDElectromedical Technologies1.00%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAMTAmerican Tower5,643466.35 million465.51 millionOptionableEMEDElectromedical Technologies8N/AN/ANot OptionableEMED, 4DX, ADR, and AMT HeadlinesSourceHeadlineMTD acquires Ypsomed's pen needle and BGM businesses, strengthening its leading position in diabetes caremsn.com - March 28 at 1:54 PMElectromedical Technologies Incthestreet.com - October 26 at 8:59 PMElectromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement.finance.yahoo.com - March 22 at 12:51 PMElectromedical Technologies expects Q4 revenue to be up 79% Y/Ymsn.com - March 14 at 11:24 AMElectromedical Technologies, Inc. (EMED)finance.yahoo.com - January 2 at 2:02 PMElectromedical Technologies Announces Financial and Operational Highlights for the Three and Nine Months Ended September 30, 2022finance.yahoo.com - December 5 at 8:26 AMElectromedical Technologies Introduces the WellnessPro Infinity™finance.yahoo.com - November 1 at 7:58 AMEMED Electromedical Technologies, Inc.seekingalpha.com - September 20 at 5:37 PMElectromedical's Flagship WellnessPro Plus Technology on Exhibit This Week at PAINWeek 2022 in Las Vegas from Sep 6-9finance.yahoo.com - September 8 at 10:38 AMElectromedical Technologies Announces Financial and Operational Highlights for the Three and Six Months Ended June 30, 2022finance.yahoo.com - August 18 at 9:51 AMElectromedical Technologies Announces Financial and Operational Highlights for the Three Months Ended March 31, 2022finance.yahoo.com - May 24 at 6:41 AMElectromedical Technologies Announces 2021 Annual Financial Resultsfinance.yahoo.com - April 7 at 11:32 AMElectromedical Technologies Inc (EMED)nasdaq.com - January 17 at 9:05 PMElectromedical Technologies, Inc. Reports Third Quarter 2021 Financial Resultsfinance.yahoo.com - November 18 at 1:37 PMElectromedical Technologies Receives Key Medical Device Certificationfinance.yahoo.com - September 30 at 8:05 AMElectromedical Technologies Clarifies Comparative Six-Month Highlights Reported in August 18, 2021 Press Releasefinance.yahoo.com - August 19 at 3:38 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAmerican TowerNYSE:AMTAmerican Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.Electromedical TechnologiesOTCMKTS:EMEDElectromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. It offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. The company also develops WellnessPro POD, a compact clinical-grade wearable device for pain management; and Wellness ION Pen, an interferential cold laser used to deliver targeted frequency stimulation to improve circulation and tissue healing, and reduce inflammation and pain. Electromedical Technologies, Inc. was founded in 2002 and is headquartered in Scottsdale, Arizona. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.